Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-025148

Chief Commercial Officer sold 8,518 shares at an average $40.03 ($341,015)

  • Chief Commercial Officer acquired 4,459 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dierks Jeffrey Chief Commercial Officer 2022-02-16 Option exercise +4,259 $24.00 $102,216 4,259 D: show line 1 in the form
Dierks Jeffrey Chief Commercial Officer 2022-02-16 Sale −4,259 $40.05 $170,591 0 D: show line 2 in the form
Dierks Jeffrey Chief Commercial Officer 2022-02-17 Option exercise +200 $24.00 $4,800 200 D: show line 3 in the form
Dierks Jeffrey Chief Commercial Officer 2022-02-17 Sale −4,259 $40.02 $170,424 0 D: show line 4 in the form
Open-market sales · 8,518 sh · avg $40.03 · $341,015

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Dierks Jeffrey Chief Commercial Officer 2022-02-16 Option exercise · Stock Option −4,259 140,597 D: show line 5 in the form
Dierks Jeffrey Chief Commercial Officer 2022-02-17 Option exercise · Stock Option −200 140,397 D: show line 6 in the form
Loading xslF345X03/tm227120-1_4seq1.xml…